Formosa Pharmaceuticals, Inc. (TPE:6838)

Taiwan · Delayed Price · Currency is TWD

23.40

-1.30 (-5.26%)

Jul 30, 2026, 1:30 PM CST

Formosa Pharmaceuticals Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	54.32	9.5	143.36	31.17	1.32	28.53
Revenue Growth	236.36%	-93.38%	359.89%	2270.49%	-95.39%	-
Gross Profit	38.56	-1.6	118.99	27.35	0.33	28.26
Operating Income	-146.35	-170.61	-175.63	-283.04	-381.67	-380.01
Net Income	-58.08	-83.57	-201.01	-321.96	-406.27	-400.88
Earnings Per Share	-0.38	-0.55	-1.43	-2.59	-3.86	-4.33
EPS Growth	-	-	-	-	-	-

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Taiwan	-	0.37	-	1.32	28.53
Asia	4.73	7.16	31.17	-	-
America	4.76	135.82	-	-	-
Total	9.5	143.36	31.17	1.32	28.53

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1,383	1,442	1,646	1,216	420.89	208.92
Total Debt	25.32	26.99	25.8	29.79	6.9	3.18
Net Cash (Debt)	1,358	1,415	1,620	1,186	413.99	205.74
Net Cash Growth	-13.53%	-12.67%	36.55%	186.56%	101.22%	476.99%
Net Cash Per Share	8.99	9.37	11.50	9.56	3.94	2.22

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-82.65	-95.64	-128.68	-196.04	-346.15	-331.13
Capital Expenditures	-1.34	-10.01	-7.27	-2.17	-	-0.22
Free Cash Flow	-84	-105.65	-135.95	-198.21	-346.15	-331.35
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	70.98%	-16.83%	83.00%	87.73%	25.32%	99.06%
Operating Margin	-269.40%	-1796.85%	-122.51%	-907.98%	-29024.26%	-1332.01%
Pretax Margin	-106.93%	-884.72%	-125.26%	-962.61%	-30919.62%	-1396.55%
Profit Margin	-106.92%	-880.10%	-140.22%	-1032.84%	-30895.21%	-1405.18%
FCF Margin	-154.63%	-1112.70%	-94.83%	-635.85%	-26323.19%	-1161.46%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	68.65	419.78	39.44	214.95	4502.47	118.82